Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study

by Ryoo Baek-Yeol, Chang Heung-Moon, Lee Jae-Lyun, Ryu Min-Hee, Hong Yong, Yun Sung-Cheol, Koo Dong, Kang Yoon-Koo, Kim Tae
Published 2011-05-01

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study

by Lee, Kyung Hee, Kim, Min Kyoung, Kim, Yeol Hong, Ryoo, Baek Yeol, Lim, Ho Yeong, Song, Hong Suk, Kim, Hoon Kyo, Lee, Myung Ah, Im, Seock Ah, Chang, Heung Moon, Cho, Jae Yong, Zang, Dae Young, Kim, Bong Seog, Kim, Jun Suk]
Published 2022

Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer

by Paik, Kwang Hyun, Park, Yeon Hee, Ryoo, Baek-Yeol, Yang, Sung Hyun, Lee, Jae Cheol, Kim, Cheol Hyun, Ki, Seung Seog, Kim, Jung Min, Park, Myung Joon, Ahn, Heui June, Choi, Won, Chung, Jin Haeng
Published 2009

Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of lmatinib and Sunitinib: A Multicenter Study Based on the Managem...

by Son, Myoung Kyun, Ryu, Min-Hee, Park, Joon Oh, Im, Seock-Ah, Kim, Tae-Yong, Lee, Su Jin, Ryoo, Baek-Yeol, Park, Sook Ryun, Kang, Yoon-Koo]
Published 2022

A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor

by Ryu, Min-Hee, Kang, Won Ki, Bang, Yung-Jue, Lee, Kyung Hee, Shin, Dong Bok, Ryoo, Baek-Yeol, Roh, Jae Kyung, Kang, Jin-Hyoung, Lee, Hyoungnam, Kim, Tae Won, Chang, Heung Moon, Park, Joon Oh, Park, Young Suk, Kim, Tae-You, Kim, Min Kyoung, Lee, Woon Kee, Kang, Hye Jin, Kang, Yoon-Koo
Published 2021

Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis

by Park, Joon Oh, Ryoo, Baek-Yeol, Yen, Chia-Jui, Kudo, Masatoshi, Yang, Ling, Abada, Paolo B., Cheng, Rebecca, Orlando, Mauro, Zhu, Andrew X., Okusaka, Takuji
Published 2017

Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study

by Kang, Hye Jin, Ryu, Min-Hee, Kim, Kyoung-Mee, Park, Young Soo, Choi, Jene, Ryoo, Baek-Yeol, Kim, Woo Ho, Im, Seock-Ah, Bang, Yung-Jue, Park, Se Hoon, Lee, Jae-Hyuk, Chung, Ik Joo, Bae, Han-Ik, Kim, Jong Gwang, Lee, Kyung Hee, Song, Hong Suk, Kwon, Hyuk-Chan, Baek, Jin Ho, Shin, Dong Bok, Lee, Kyoung Eun, Kang, Yoon-Koo]
Published 2021

Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial.

by Kelley, Robin Kate, Ryoo, Baek-Yeol, Merle, Philippe, Park, Joong-Won, Bolondi, Luigi, Chan, Stephen L, Lim, Ho Yeong, Baron, Ari D, Parnis, Francis, Knox, Jennifer, Cattan, Stéphane, Yau, Thomas, Lougheed, Julie C, Milwee, Steven, El-Khoueiry, Anthony B, Cheng, Ann-Lii, Meyer, Tim, Abou-Alfa, Ghassan K
Published 2020

An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intraveno...

by El Dika, Imane, Lim, Ho Yeong, Yong, Wei Peng, Lin, Chia-Chi, Yoon, Jung-Hwan, Modiano, Manuel, Freilich, Bradley, Choi, Hye Jin, Chao, Tsu-Yi, Kelley, Robin K, Brown, Joanne, Knox, Jennifer, Ryoo, Baek-Yeol, Yau, Thomas, Abou-Alfa, Ghassan K
Published 2019

Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comp...

by Kotaka, Masahito, Xu, Ruihua, Muro, Kei, Park, Young Suk, Morita, Satoshi, Iwasa, Satoru, Uetake, Hiroyuki, Nishina, Tomohiro, Nozawa, Hiroaki, Matsumoto, Hiroshi, Yamazaki, Kentaro, Han, Sae-Won, Wang, Wei, Ahn, Joong Bae, Deng, Yanhong, Cho, Sang-Hee, Ba, Yi, Lee, Keun-Wook, Zhang, Tao, Satoh, Taroh, Buyse, Marc E., Ryoo, Baek-Yeol, Shen, Lin, Sakamoto, Junichi, Kim, Tae Won
Published 2017